Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

AIDS-associated lymphoma.

L D Kaplan

    Bailliere'S Clinical Haematology
    |January 1, 1990
    PubMed
    Summary
    This summary is machine-generated.

    Individuals with human immunodeficiency virus (HIV) face a higher risk of developing aggressive B-cell lymphomas. These lymphomas often present with widespread disease and have poorer treatment outcomes compared to non-HIV-infected patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma.

    Annals of oncology : official journal of the European Society for Medical Oncology·2015
    Same author

    Delayed hematopoietic recovery after auto-SCT in patients receiving arsenic trioxide-based therapy for acute promyelocytic leukemia: a multi-center analysis.

    Bone marrow transplantation·2014
    Same author

    Spectral band passes for a high precision satellite sounder.

    Applied optics·2010
    Same author

    Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142--low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor. National Institute of Allergy and Infectious Diseases.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1998
    Same author

    Clinical management of human immunodeficiency virus-associated non-Hodgkin's lymphoma.

    Journal of the National Cancer Institute. Monographs·1998
    Same author

    Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1998
    Same journal

    Current status of stem cell therapy and prospects for gene therapy for the disorders of globin synthesis.

    Bailliere's clinical haematology·2000
    Same journal

    Pharmacological therapy.

    Bailliere's clinical haematology·2000
    Same journal

    Prenatal diagnosis and screening of the haemoglobinopathies.

    Bailliere's clinical haematology·2000
    Same journal

    Sickle cell disease: clinical management.

    Bailliere's clinical haematology·2000
    Same journal

    Pathophysiology of sickle cell disease.

    Bailliere's clinical haematology·2000
    Same journal

    Thalassaemia: clinical management.

    Bailliere's clinical haematology·2000
    See all related articles

    Area of Science:

    • Oncology
    • Immunology
    • Virology

    Background:

    • Human immunodeficiency virus (HIV)-infected individuals are susceptible to high-grade B-cell malignancies.
    • The etiology of these lymphomas in HIV patients is largely unknown.
    • Epstein-Barr virus is detected in a minority of HIV-associated lymphomas, unlike in transplant recipients.

    Purpose of the Study:

    • To investigate the characteristics and outcomes of B-cell malignancies in HIV-infected individuals.
    • To compare lymphoma presentation and response to treatment in HIV-infected versus non-HIV-infected patients.
    • To identify prognostic factors influencing survival in HIV-associated lymphomas.

    Main Methods:

    • Classification of lymphomas based on histological subtypes (diffuse large-cell, small non-cleaved cell).

    Related Experiment Videos

  • Analysis of disease presentation, including extranodal and central nervous system involvement.
  • Evaluation of therapeutic response, relapse rates, and survival data.

    • Main Results:

    • The majority of lymphomas are diffuse large-cell types; approximately one-third are high-grade small non-cleaved cell lymphomas.
    • Patients frequently present with widespread extranodal disease, with 25% experiencing central nervous system involvement.
    • Outcomes are poorer in HIV-infected patients, with lower complete response rates and shorter survival.
    • Prognosis is improved by absence of AIDS diagnosis, higher CD4 counts, and less extensive disease.
    • Hodgkin's disease in HIV-infected individuals shows aggressive behavior with poor treatment response.

    Conclusions:

    • HIV-associated B-cell lymphomas are aggressive, often widespread, and associated with poor therapeutic outcomes.
    • Factors like CD4 count and disease extent significantly impact prognosis.
    • Hodgkin's disease also follows a more aggressive course in the context of HIV infection, complicating treatment.